Clinical Trials
3 trialsNCT01695005 2025-12-26
A Study of LY3039478 in Participants With Advanced Cancer
Eli Lilly and Company
Phase 1 Completed
NCT02784795 2025-08-21
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Phase 1 Terminated
NCT02836600 2025-08-07
A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors
Eli Lilly and Company
Phase 1 Completed